Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01146379 · ClinicalTrials.gov registry record · Phase 2

Does More Practice Improve Arm Movement After Stroke?

A Phase 2 study of Stroke, sponsored by Washington University School of Medicine.

Completed
Registry status
Phase 2
Development phase
85
Enrollment target
1
Study location

NCT01146379: Completed Phase 2 study of Stroke, sponsored by Washington University School of Medicine.

NCT01146379 is a Phase 2 study of Stroke that has completed, run by Washington University School of Medicine. The registered enrollment target is 85 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01146379, a Phase 2 study of Stroke, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
Phase 2
Development phase
85 participants
Enrollment target
1
Study location

Study Summary

Arm weakness happens a lot after a stroke. People often get physical or occupational therapy after their stroke to learn how to use their arm again. This study will help figure out how much therapy should be given to restore as much arm function as possible.

Primary Outcome

The Action Research Arm Test (ARAT) is a standardized assessment of upper extremity functional capacity. Criterion scores are awarded by a trained assessor as the person performs 19 different items requiring reaching, grasping, and manipulation of various objects. Maximum total score is 57. Minimum total score is 0. Higher scores represent better arm and hand functional capacity. In this study, scores were assesses weekly and the analysis evaluated the rate of change over time in units/week.

Conditions Studied

Interventions

  • OTHER Intensive task-specific upper extremity rehabilitation

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2010-05
Est. Completion 2015-10
Phase Phase 2

What the finished NCT01146379 record still lists

NCT01146379 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Intensive task-specific upper extremity rehabilitation is the first listed.

NCT01146379 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT01146379 about?

NCT01146379 is a clinical study titled "Does More Practice Improve Arm Movement After Stroke?". Arm weakness happens a lot after a stroke. People often get physical or occupational therapy after their stroke to learn how to use their arm again. This study will help figure out how much therapy should be given to restore as much arm function as possible.

What is the current status of trial NCT01146379?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 85 participants. The study started on 2010-05. Estimated completion is 2015-10.

What conditions does trial NCT01146379 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT01146379?

The interventions under investigation include: Intensive task-specific upper extremity rehabilitation (OTHER).

Who is sponsoring clinical trial NCT01146379?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01146379 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01146379's enrollment target sits among peer trials

85 162nd of 454 higher than 292 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00842283 · 85 participants

    Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

  • NCT02133196 · 85 participants · Phase 2

    T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

  • NCT03823144 · 85 participants · NA

    Intravital Microscopy in Human Solid Tumors

  • NCT03875638 · 85 participants · Phase 2

    Treating Hyperexcitability in AD With Levetiracetam

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01146379, the US trial registry maintained by the National Library of Medicine. NCT01146379 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.